Vidya Raman-Tangella - May 31, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
May 31, 2024
Transactions value $
-$55,877
Form type
4
Date filed
6/4/2024, 04:06 PM
Previous filing
May 2, 2024
Next filing
Aug 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +792 +2.72% 30K May 31, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +2.33K +7.76% 32.3K May 31, 2024 Direct F2
transaction TDOC Common Stock Sale -$38.2K -3.41K -10.56% $11.21 28.9K May 31, 2024 Direct F3
transaction TDOC Common Stock Sale -$12.5K -1.12K -3.89% $11.16 27.7K Jun 3, 2024 Direct F4
transaction TDOC Common Stock Sale -$5.17K -468 -1.69% $11.04 27.3K Jun 4, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -792 -12.49% $0.00 5.55K May 31, 2024 Common Stock 792 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -2.33K -12.5% $0.00 16.3K May 31, 2024 Common Stock 2.33K Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.
F4 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F5 On March 1, 2024, the reporting person earned 9,509 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 27,902 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.